← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2019Last known activity
Mar 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04754061CollaboratorPhase 1/Phase 2Mar 31, 2022
- NCT04001010Overall official - principal investigatorPhase 3Sep 1, 2019
Details
- Last known activity
- Mar 31, 2022